More on reports of esophageal cancer with oral bisphosphonate use

N Engl J Med. 2009 Apr 23;360(17):1789; author reply 1791-2. doi: 10.1056/NEJMc096026.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Administration, Oral
  • Bone Density Conservation Agents / adverse effects*
  • Confidence Intervals
  • Diphosphonates / adverse effects*
  • Esophageal Neoplasms / chemically induced*
  • Follow-Up Studies
  • Fractures, Bone / drug therapy
  • Humans
  • Proportional Hazards Models
  • Risk Assessment
  • Stomach Neoplasms / chemically induced*

Substances

  • Bone Density Conservation Agents
  • Diphosphonates